U.S. PHYSICAL THERAPY INC (USPH) Stock Earnings & Estimates
USA - NYSE:USPH - US90337L1089 - Common Stock
87.1 USD
-2.84 (-3.16%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 553.1M 11.74% | 604.802M 9.35% | 671.345M 11.00% | 788.9M 17.51% | 837.25M 6.13% | 902.93M 7.84% | |
| EBITDA YoY % growth | 80.64M -2.01% | 85.251M 5.72% | 88.667M 4.01% | 96.772M 9.14% | 105.26M 8.77% | 115.58M 9.80% | |
| EBIT YoY % growth | 65.9M -6.79% | 69.556M 5.55% | 69.986M 0.62% | 85.088M 21.58% | 90.123M 5.92% | 97.912M 8.64% | |
| Operating Margin | 11.91% | 11.50% | 10.42% | 10.79% | 10.76% | 10.84% | |
| EPS YoY % growth | 2.71 -14.51% | 2.56 -5.54% | 2.58 0.78% | 2.82 9.38% | 3.12 10.54% | 3.43 10.03% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.68 -0.96% | 0.70 7.75% | 0.62 29.63% | 0.88 8.30% | 0.82 19.40% | 0.80 13.59% |
| Revenue Q2Q % growth | 197.84M 17.74% | 201.67M 11.76% | 200.31M 8.99% | 212.94M 7.90% | 211.2M 6.75% | 215.87M 7.04% |
| EBITDA Q2Q % growth | 24.405M -21.71% | 25.217M -29.72% | 23.398M -9.14% | 28.794M -22.03% | 27.291M 11.83% | 26.842M 6.44% |
| EBIT Q2Q % growth | 20.452M 12.51% | 21.483M 24.89% | 19.307M -2.90% | 26.674M 6.67% | 22.641M 10.70% | 23.089M 7.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.81 10.96% | 0.73 | 0.08 | 11.07% |
| Q1 2025 Q2Q % growth | 0.48 -5.88% | 0.44 | 0.04 | 9.44% |
| Q4 2024 Q2Q % growth | 0.65 10.17% | 0.70 | -0.05 | -7.64% |
| Q3 2024 Q2Q % growth | 0.69 11.29% | 0.70 | -0.01 | -1.00% |
| Q2 2024 Q2Q % growth | 0.73 -3.95% | 0.83 | -0.10 | -12.54% |
| Q1 2024 Q2Q % growth | 0.51 -13.56% | 0.57 | -0.06 | -10.45% |
| Q4 2023 Q2Q % growth | 0.59 1.72% | 0.58 | 0.01 | 2.08% |
| Q3 2023 Q2Q % growth | 0.62 6.90% | 0.63 | -0.01 | -1.43% |
| Q2 2023 Q2Q % growth | 0.76 -15.56% | 0.76 | 0.00 | -0.39% |
| Q1 2023 Q2Q % growth | 0.59 -9.23% | 0.56 | 0.03 | 6.13% |
| Q4 2022 Q2Q % growth | 0.58 -19.44% | 0.58 | 0.00 | -0.24% |
| Q3 2022 Q2Q % growth | 0.58 -31.76% | 0.57 | 0.01 | 1.18% |
| Q2 2022 Q2Q % growth | 0.90 -6.25% | 0.96 | -0.06 | -6.73% |
| Q1 2022 Q2Q % growth | 0.65 1.56% | 0.65 | 0.00 | 0.75% |
| Q4 2021 Q2Q % growth | 0.72 -15.29% | 0.70 | 0.02 | 2.60% |
| Q3 2021 Q2Q % growth | 0.85 | 0.79 | 0.06 | 7.11% |
| Q2 2021 Q2Q % growth | 0.96 12.94% | 0.74 | 0.22 | 29.64% |
| Q1 2021 Q2Q % growth | 0.64 113.33% | 0.48 | 0.16 | 33.50% |
| Q4 2020 Q2Q % growth | 0.85 32.81% | 0.85 | 0.00 | 0.16% |
| Q3 2020 Q2Q % growth | 0.85 19.72% | 0.52 | 0.33 | 62.76% |
| Q2 2020 Q2Q % growth | 0.85 4.94% | -0.18 | 1.03 | 562.96% |
| Q1 2020 Q2Q % growth | 0.30 -54.55% | 0.41 | -0.11 | -26.84% |
| Q4 2019 Q2Q % growth | 0.64 | 0.70 | -0.06 | -8.40% |
| Q3 2019 Q2Q % growth | 0.71 | 0.73 | -0.02 | -2.42% |
| Q2 2019 Q2Q % growth | 0.81 | 0.83 | -0.02 | -1.96% |
| Q1 2019 Q2Q % growth | 0.66 | 0.62 | 0.04 | 7.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 197.344M 18.04% | 193.39M | 3.954M | 2.04% |
| Q1 2025 Q2Q % growth | 183.788M 18.06% | 180.8M | 2.988M | 1.65% |
| Q4 2024 Q2Q % growth | 180.447M 16.57% | 178.27M | 2.177M | 1.22% |
| Q3 2024 Q2Q % growth | 168.033M 12.02% | 167.67M | 363K | 0.22% |
| Q2 2024 Q2Q % growth | 167.19M 10.37% | 165.57M | 1.62M | 0.98% |
| Q1 2024 Q2Q % growth | 155.675M 4.83% | 156.43M | -755K | -0.48% |
| Q4 2023 Q2Q % growth | 154.801M 9.63% | 153.28M | 1.521M | 0.99% |
| Q3 2023 Q2Q % growth | 150.007M 7.45% | 151.89M | -1.883M | -1.24% |
| Q2 2023 Q2Q % growth | 151.485M 7.67% | 154.08M | -2.595M | -1.68% |
| Q1 2023 Q2Q % growth | 148.509M 12.76% | 143.58M | 4.929M | 3.43% |
| Q4 2022 Q2Q % growth | 141.2M 8.78% | 144.01M | -2.81M | -1.95% |
| Q3 2022 Q2Q % growth | 139.6M 10.88% | 140.99M | -1.39M | -0.99% |
| Q2 2022 Q2Q % growth | 140.7M 10.87% | 145.95M | -5.25M | -3.60% |
| Q1 2022 Q2Q % growth | 131.7M 17.17% | 131.08M | 620K | 0.47% |
| Q4 2021 Q2Q % growth | 129.8M 10.47% | 131.09M | -1.29M | -0.98% |
| Q3 2021 Q2Q % growth | 125.9M 15.61% | 127.27M | -1.37M | -1.08% |
| Q2 2021 Q2Q % growth | 126.9M 51.25% | 125.02M | 1.88M | 1.50% |
| Q1 2021 Q2Q % growth | 112.4M -0.27% | 113.26M | -860K | -0.76% |
| Q4 2020 Q2Q % growth | 117.5M -3.77% | 118.69M | -1.19M | -1.00% |
| Q3 2020 Q2Q % growth | 108.9M -7.16% | 105.59M | 3.31M | 3.13% |
| Q2 2020 Q2Q % growth | 83.9M -33.62% | 89.421M | -5.521M | -6.17% |
| Q1 2020 Q2Q % growth | 112.7M -3.01% | 108.73M | 3.97M | 3.65% |
| Q4 2019 Q2Q % growth | 122.1M | 123.91M | -1.81M | -1.46% |
| Q3 2019 Q2Q % growth | 117.3M | 123.65M | -6.35M | -5.14% |
| Q2 2019 Q2Q % growth | 126.4M | 127.31M | -910K | -0.71% |
| Q1 2019 Q2Q % growth | 116.2M | 118.37M | -2.17M | -1.83% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.55% | 0% | 8.84% |
| Revenue | 0% | 1.67% | 0% | 1.76% |